- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06118606
Pilot Study of a Multidisciplinary Intervention in ICU Survivors at Risk for Psychological or Physical Morbidity (IMPRESS)
Interventional Multidisciplinary Rehabilitation and Special Support; a Pilot Study of a Case Manager-led Multidisciplinary Intervention in ICU Survivors at Risk for Psychological or Physical Morbidity -IMPRESS-ICU Pilot Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
60 adult patients at two hospitals in Region Stockholm (Karolinska University Hospital and Södersjukhuset) with an ICU stay ≥12 hours with increased risk for psychological/physical sequelae will be invited to participate.
Intervention: Early re-assessment and multidisciplinary follow-up, led by an ICU follow-up staff (Case Manager, CM). The CM will support the patient and coordinate the rehabilitation efforts from ICU discharge to primary care with a secondary, deepened assessment of symptoms in the ward, recapitulation and information about the time spent in the ICU, followed by a multidisciplinary discussion with concerned specialists and the set-up of an individual rehabilitation plan communicated to the patient and the informal caregivers. The CM will keep track of the patient during hospital stay and ensure that there is a plan for further primary care rehabilitation after hospital discharge. The CM will contact the patient weekly to follow up on wellbeing and planned primary care activities until 12 weeks. At twelve weeks, patients will be assessed with regards to psychological symptoms (HADS, PTSS-14) and physical disability (BI).
Outcome: The primary outcome is the feasibility of the intervention. Patients and informal caregivers will be invited to participate in semi-structured interviews that will deepen the knowledge about their views upon the intervention, needs and suggested measures to improve the patients' recovery. Resource utilisation will be documented by the CM and feedback collected from involved ICU staff and hospital clinicians. Secondary outcomes are patients' level of psychological and physical problems and health-related quality of life. The results from the pilot study will inform a subsequent randomized controlled trial of an early follow-up intervention.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Stockholm, Sweden, 113 45
- ICU Karolinska University Hospital
-
Stockholm, Sweden
- ICU Södersjukhuset
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients admitted ≥12 hours to the ICU with an increased risk for physical or psychological sequelae (assessed with the PROGRESS-ICU/PREPICS instruments)
Exclusion Criteria:
- Dementia or other major cognitive problems
- Structural brain or spinal cord injury
- Multiple limitations of medical treatment
- Insufficient language skills (Swedish)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Interventional arm
Intervention arm
|
Early in-hospital follow-up in survivors of intensive care with an increased risk of psychological/physical sequelae.
The follow-up is led by a case-manager reassessing the patient after ICU discharge for psychological/physical rehabilitation needs.
The CM will discuss patient needs with concerned specialists in a multidisciplinary team, leading to the establishment of a personal rehabilitation plan, communicated to the patient and next-of-kin.
The CM will keep track of the patient during hospital stay and ensure primary care rehabilitation (if needed) is established once the patient is discharged from the hospital.
The CM will contact the patient weekly to follow up on well-being and primary care activities until 12 weeks after discharge.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of the intervention
Time Frame: Outcome measured during and after termination of data collection and end of intervention
|
Evaluation of the method including resource utilization with involved ICU follow-up staff/case managers and patients and their informal caregivers.
|
Outcome measured during and after termination of data collection and end of intervention
|
|
Utility of the intervention
Time Frame: Outcome measured three-four months after ICU discharge
|
Patient and caregiver views on the intervention's utility.
Views on the intervention from hospital ward staff.
|
Outcome measured three-four months after ICU discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depressive symptoms post-ICU
Time Frame: Outcome measured three months after ICU discharge
|
Assessment of patients' symptoms of depression post-intervention
|
Outcome measured three months after ICU discharge
|
|
Anxiety symptoms post-ICU
Time Frame: Outcome measured three months after ICU discharge
|
Assessment of patients' symptoms of anxiety post-intervention
|
Outcome measured three months after ICU discharge
|
|
Symptoms of post-traumatic stress post-ICU
Time Frame: Outcome measured three months after ICU discharge
|
Assessment of patients' symptoms of post-traumatic stress post-intervention
|
Outcome measured three months after ICU discharge
|
|
Physical disability post-ICU
Time Frame: Outcome measured three months after ICU discharge
|
Assessment of physical performance post-intervention
|
Outcome measured three months after ICU discharge
|
|
Health-related quality of life post-ICU
Time Frame: Outcome measured three months after ICU discharge
|
Health-related quality of life (HRQL) assessed with the RAND-36 questionnaire, scoring 0-100 where a higher score indicates greater HRQL.
|
Outcome measured three months after ICU discharge
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Anna Milton, Karolinska Institutet/Karolinska University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022-03436-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.